NCT04829448

Brief Summary

SpineZone is an innovative physical therapy program with its focus on treatment of cervical, thoracic, and lumbar conditions through the use of a multi-disciplinary, technology enabled platform. Standard physical therapy modalities including exercise-based rehabilitation as well as patient education on a healthy lifestyle (sleep, nutrition, posture) are employed as part of the standard treatment. As nutrition is a key element in modulating muscle growth and function in response to exercise, providing patients with appropriate access to nutritional supplements that meet the metabolic demands of our exercise program are potentially important to our clinical outcomes.

Trial Health

33
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Trial recruitment is currently suspended
Enrollment
100

participants targeted

Target at P75+ for not_applicable low-back-pain

Timeline
Completed

Started Mar 2022

Longer than P75 for not_applicable low-back-pain

Geographic Reach
1 country

1 active site

Status
suspended

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 30, 2021

Completed
3 days until next milestone

First Posted

Study publicly available on registry

April 2, 2021

Completed
12 months until next milestone

Study Start

First participant enrolled

March 16, 2022

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 1, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 1, 2026

Completed
Last Updated

November 29, 2024

Status Verified

November 1, 2024

Enrollment Period

4 years

First QC Date

March 30, 2021

Last Update Submit

November 26, 2024

Conditions

Keywords

Protein SupplementExercise-based Rehabilitation

Outcome Measures

Primary Outcomes (1)

  • Muscle size

    Change in spine extensor muscle cross sectional area (cm2)

    3 months, 6 months, 1 year, 2 years

Secondary Outcomes (4)

  • Symptom inference - change in pain. Visual Analogue Scale (VAS), 0-100mm

    3 months, 6 months, 1 year, 2 years

  • Change in disability

    3 months, 6 months, 1 year, 2 years

  • Patient Goal Achievement

    3 months, 6 months

  • Change in strength (lbs*deg)

    3 months, 6 months, 1 year, 2 years

Study Arms (2)

Protein Intervention Group

EXPERIMENTAL

Patients who receive the protein nutritional supplement as part of their prescribed exercise-based rehabilitation program.

Dietary Supplement: Protein supplement

Control Group

NO INTERVENTION

Patients who receive the prescribed exercise-based rehabilitation program, without protein supplement.

Interventions

Protein supplementDIETARY_SUPPLEMENT

Protein supplement equivalent to Metagenics Ultrameal

Protein Intervention Group

Eligibility Criteria

Age18 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Seeking treatment for spinal conditions, pain or for the prevention of future injury
  • Ability to consume protein shake and follow storage, timing and preparation instructions
  • Indicated by a qualified health care provider to safely participate in an exercise-based rehabilitation program
  • Ability to read and comprehend the English language

You may not qualify if:

  • Certain medical conditions, diagnosis, physical or psychological or physical exam finding that precludes participation, medications, or contraindications for protein supplement
  • Individuals who are determined by their health care provider to be contraindicated for participation in an exercise-based rehabilitation program
  • Individuals with food allergies to animal based products, nuts, and/or eggs
  • Individuals with consumption preferences omitting non-vegan or vegetarian products
  • Taking protein supplements already
  • History of severe liver disorder
  • History of Kidney disorder
  • History of diabetes
  • History of Gastrointestinal malabsorption
  • History of Parathyroid gland disorders
  • Pregnant, postpartum up to six months, lactating, or intention to become pregnant

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

SpineZone

San Diego, California, 92108, United States

Location

MeSH Terms

Conditions

Low Back Pain

Condition Hierarchy (Ancestors)

Back PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Officials

  • Bahar Shahidi, PT, PhD

    UCSD Orthopedic Surgery

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR INVESTIGATOR
PI Title
Chairman, Cheif Medical Officer

Study Record Dates

First Submitted

March 30, 2021

First Posted

April 2, 2021

Study Start

March 16, 2022

Primary Completion

April 1, 2026

Study Completion

April 1, 2026

Last Updated

November 29, 2024

Record last verified: 2024-11

Data Sharing

IPD Sharing
Will not share

Patient data will only be accessible to SpineZone and collaborating research partners (UCSD).

Locations